1-11212411-C-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The ENST00000361445.9(MTOR):ā€‹c.3462G>Cā€‹(p.Arg1154Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00738 in 1,614,122 control chromosomes in the GnomAD database, including 412 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Synonymous variant affecting the same amino acid position (i.e. R1154R) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.011 ( 68 hom., cov: 32)
Exomes š‘“: 0.0070 ( 344 hom. )

Consequence

MTOR
ENST00000361445.9 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.223
Variant links:
Genes affected
MTOR (HGNC:3942): (mechanistic target of rapamycin kinase) The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This kinase is a component of two distinct complexes, mTORC1, which controls protein synthesis, cell growth and proliferation, and mTORC2, which is a regulator of the actin cytoskeleton, and promotes cell survival and cell cycle progression. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. Inhibitors of mTOR are used in organ transplants as immunosuppressants, and are being evaluated for their therapeutic potential in SARS-CoV-2 infections. Mutations in this gene are associated with Smith-Kingsmore syndrome and somatic focal cortical dysplasia type II. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 1-11212411-C-G is Benign according to our data. Variant chr1-11212411-C-G is described in ClinVar as [Benign]. Clinvar id is 414901.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-11212411-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.223 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0612 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MTORNM_004958.4 linkuse as main transcriptc.3462G>C p.Arg1154Arg synonymous_variant 23/58 ENST00000361445.9 NP_004949.1 P42345

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MTORENST00000361445.9 linkuse as main transcriptc.3462G>C p.Arg1154Arg synonymous_variant 23/581 NM_004958.4 ENSP00000354558.4 P42345

Frequencies

GnomAD3 genomes
AF:
0.0112
AC:
1706
AN:
152154
Hom.:
67
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00316
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0645
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0449
Gnomad SAS
AF:
0.0655
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.0100
GnomAD3 exomes
AF:
0.0198
AC:
4976
AN:
251248
Hom.:
169
AF XY:
0.0200
AC XY:
2713
AN XY:
135778
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.0641
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0411
Gnomad SAS exome
AF:
0.0600
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000211
Gnomad OTH exome
AF:
0.0153
GnomAD4 exome
AF:
0.00698
AC:
10208
AN:
1461850
Hom.:
344
Cov.:
31
AF XY:
0.00832
AC XY:
6050
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00311
Gnomad4 AMR exome
AF:
0.0624
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0375
Gnomad4 SAS exome
AF:
0.0581
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000156
Gnomad4 OTH exome
AF:
0.0102
GnomAD4 genome
AF:
0.0112
AC:
1708
AN:
152272
Hom.:
68
Cov.:
32
AF XY:
0.0140
AC XY:
1041
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00322
Gnomad4 AMR
AF:
0.0645
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0450
Gnomad4 SAS
AF:
0.0649
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.000265
Gnomad4 OTH
AF:
0.00992
Alfa
AF:
0.00192
Hom.:
7
Bravo
AF:
0.0132
EpiCase
AF:
0.000382
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 17, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
8.7
DANN
Benign
0.70
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17036536; hg19: chr1-11272468; COSMIC: COSV63869843; API